Paxman AB (publ) (STO:PAX)

Market Cap	1.59B
Revenue (ttm)	283.78M
Net Income (ttm)	8.64M
Shares Out	23.27M
EPS (ttm)	0.43
PE Ratio	156.79
Forward PE	34.88
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,524
Average Volume	36,309
Open	68.00
Previous Close	68.00
Day's Range	66.80 - 68.60
52-Week Range	59.80 - 85.80
Beta	0.29
RSI	51.68
Earnings Date	Nov 14, 2025

About Paxman AB

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to develop a wearable medical cooling device; and the National University Hospital of Singapore for the development of a cooling and compression system. Paxman AB (publ) was founded in 1996 and is headquartered in Karlshamn, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 105
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: PAX

Financial Performance

In 2024, Paxman AB's revenue was 263.20 million, an increase of 19.30% compared to the previous year's 220.61 million. Earnings were 40.20 million, an increase of 382.55%.